Charles V. Baltic III, Director at MEI Pharma, Inc. (MEIP), bought 15,000 shares at $0.43 ($6K) on 2012-07-05, disclosed to the SEC on 2012-07-09.
Open-market purchase of $6k MEIP by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| MEIP | SELL | 2017-11-29 | $24K | — | Filing → |
| MEIP | BUY | 2015-01-23 | $19K | — | Filing → |
| MEIP | BUY | 2015-01-02 | $13K | — | Filing → |